Sponsors (10)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced May 8, 2025 by Kevin Hern · Last progress 10 months ago
Requires Medicare and Medicaid to cover "prescription digital therapeutics" and sets rules for how those products are paid, coded, and reported. Medicare coverage and manufacturer reporting begin January 1, 2026; the Secretary must establish a payment method within one year and product-specific HCPCS codes within two years. Manufacturers must report private-payor prices, sales volumes, and user counts, and false reporting can trigger civil money penalties.
The law adds prescription digital therapeutics to the list of Medicaid-covered items and protects reported data under existing confidentiality rules while requiring reported prices to reflect discounts and rebates.
